1,709
Views
20
CrossRef citations to date
0
Altmetric
MIATA Compliant Research Paper

TARP vaccination is associated with slowing in PSA velocity and decreasing tumor growth rates in patients with Stage D0 prostate cancer

, , , , , , , , , , , , , , , , , & show all
Article: e1197459 | Received 13 May 2016, Accepted 30 May 2016, Published online: 03 Aug 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Lucillia Bezu, Oliver Kepp, Giulia Cerrato, Jonathan Pol, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial watch: Peptide-based vaccines in anticancer therapy. OncoImmunology 7:12.
Read now
John C. Henegan & Guru Sonpavde. (2018) Promising immunotherapy for prostate cancer. Expert Opinion on Biological Therapy 18:2, pages 109-120.
Read now

Articles from other publishers (18)

Jakub Karwacki, Aleksander Kiełbik, Wojciech Szlasa, Natalia Sauer, Kamil Kowalczyk, Wojciech Krajewski, Jolanta Saczko, Julita Kulbacka, Tomasz Szydełko & Bartosz Małkiewicz. (2022) Boosting the Immune Response—Combining Local and Immune Therapy for Prostate Cancer Treatment. Cells 11:18, pages 2793.
Crossref
Jay A. Berzofsky, Savannah B. Howe & Purevdorj B. Olkhanud. 2022. Encyclopedia of Infection and Immunity. Encyclopedia of Infection and Immunity 76 89 .
Orsolya Lőrincz, József Tóth, Levente Molnár, István Miklós, Kata Pántya, Mónika Megyesi, Eszter Somogyi, Zsolt Csiszovszki & Enikő R. Tőke. (2021) In Silico Model Estimates the Clinical Trial Outcome of Cancer Vaccines. Cells 10:11, pages 3048.
Crossref
Jolien Vanhooren, Charlotte Derpoorter, Barbara Depreter, Larissa Deneweth, Jan Philippé, Barbara De Moerloose & Tim Lammens. (2021) TARP as antigen in cancer immunotherapy. Cancer Immunology, Immunotherapy 70:11, pages 3061-3068.
Crossref
Michelle H. Teplensky, Jasper W. Dittmar, Lei Qin, Shuya Wang, Michael Evangelopoulos, Bin Zhang & Chad A. Mirkin. (2021) Spherical Nucleic Acid Vaccine Structure Markedly Influences Adaptive Immune Responses of Clinically Utilized Prostate Cancer Targets. Advanced Healthcare Materials 10:22, pages 2101262.
Crossref
Anna Patrikidou, Thomas Zilli, Giulia Baciarello, Safae Terisse, Zineb Hamilou & Karim Fizazi. (2021) Should androgen deprivation therapy and other systemic treatments be used in men with prostate cancer and a rising PSA post-local treatments?. Therapeutic Advances in Medical Oncology 13, pages 175883592110518.
Crossref
Hoyoung M. Maeng & Jay A. Berzofsky. 2021. Principles of Translational Science in Medicine. Principles of Translational Science in Medicine 307 328 .
Boris A. Reva, Tatiana Omelchenko, Sujit S. Nair & Ashutosh K. Tewari. (2020) Immune Escape in Prostate Cancer. Urologic Clinics of North America 47:4, pages e9-e16.
Crossref
Marijo Bilusic, David J. Einstein, Fatima H. Karzai, William L. Dahut, James L. Gulley, Jeanny B. Aragon-Ching & Ravi A. Madan. (2020) The Potential Role for Immunotherapy in Biochemically Recurrent Prostate Cancer. Urologic Clinics of North America 47:4, pages 457-467.
Crossref
Shweta Tiwary, Jay A. Berzofsky & Masaki Terabe. (2019) Altered Lipid Tumor Environment and Its Potential Effects on NKT Cell Function in Tumor Immunity. Frontiers in Immunology 10.
Crossref
Hoyoung M. Maeng & Jay A. Berzofsky. (2019) Strategies for developing and optimizing cancer vaccines. F1000Research 8, pages 654.
Crossref
T. Tran, C. Blanc, C. Granier, A. Saldmann, C. Tanchot & Eric Tartour. (2018) Therapeutic cancer vaccine: building the future from lessons of the past. Seminars in Immunopathology 41:1, pages 69-85.
Crossref
Nataliya Prokhnevska, Dana A. Emerson, Haydn T. Kissick & William L. Redmond. 2019. Prostate Cancer. Prostate Cancer 121 147 .
Jay A. Berzofsky, Masaki Terabe, Jane B. Trepel, Ira Pastan, David F. Stroncek, John C. Morris & Lauren V. Wood. (2017) Cancer vaccine strategies: translation from mice to human clinical trials. Cancer Immunology, Immunotherapy 67:12, pages 1863-1869.
Crossref
Ping Jin, Wenjing Chen, Jiaqiang Ren, Steven Chen, Lauren Wood, Yingdong Zhao, Alan Remaley, Chauha Pham, Sheena Lian, Shutong Liu, Hui Liu, Steven Highfill, Jay A. Berzofsky & David F. Stroncek. (2018) Plasma from some cancer patients inhibits adenoviral Ad5f35 vector transduction of dendritic cells. Cytotherapy 20:5, pages 728-739.
Crossref
Hoyoung Maeng, Masaki Terabe & Jay A Berzofsky. (2018) Cancer vaccines: translation from mice to human clinical trials. Current Opinion in Immunology 51, pages 111-122.
Crossref
Paolo A. Ascierto, Sanjiv S. Agarwala, Gennaro Ciliberto, Sandra Demaria, Reinhard Dummer, Connie P. M. Duong, Soldano Ferrone, Silvia C. Formenti, Claus Garbe, Ruth Halaban, Samir Khleif, Jason J. Luke, Lluis M. Mir, Willem W. Overwijk, Michael Postow, Igor Puzanov, Paul Sondel, Janis M. Taube, Per Thor Straten, David F. Stroncek, Jennifer A. Wargo, Hassane Zarour & Magdalena Thurin. (2017) Future perspectives in melanoma research “Melanoma Bridge”, Napoli, November 30th–3rd December 2016. Journal of Translational Medicine 15:1.
Crossref
Luciano Castiello, Marianna Sabatino, Jiaqiang Ren, Masaki Terabe, Hanh Khuu, Lauren V. Wood, Jay A. Berzofsky & David F. Stroncek. (2017) Expression of CD14, IL10, and Tolerogenic Signature in Dendritic Cells Inversely Correlate with Clinical and Immunologic Response to TARP Vaccination in Prostate Cancer Patients. Clinical Cancer Research 23:13, pages 3352-3364.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.